论文部分内容阅读
高血压是一种心血管综合征,近年来发病率一直居高不下,治愈率不高,会增加患者其他心脑血管疾病的风险,给患者带来更大的危害,有较高的致残致死率。服药依从性差是我国广大社区高血压患者常见的问题,也是影响其治疗效果的重要因素,对其影响因素进行分析,不仅能够丰富现有研究内容,也能够为针对性解决措施的提出提供科学依据。近年来人们对社区高血压患者降压药物依从性的研究已经有了一定的进展,为了改善依从性,防止疾病的发展和并发症的发生,提高患者生活质量,降低致残率、致死率,本文根据我国高血压防治指南中规定5类降压药(β受体阻滞剂、ACEI、ARB、CCB、利尿剂)分别阐述其研究进展。
Hypertension is a cardiovascular syndrome, the incidence has been high in recent years, the cure rate is not high, will increase the risk of other cardiovascular and cerebrovascular diseases in patients with greater harm to patients with higher disability Mortality. Poor medication compliance is a common problem in the vast majority of community-based hypertensive patients, but also affect the treatment of an important factor, the analysis of its influencing factors, not only to enrich the existing research content, but also for the proposed solutions provide a scientific basis . In recent years, there has been some progress in the study on the compliance of antihypertensive drugs in community-based hypertensive patients. In order to improve adherence, prevent the development of diseases and complications, improve the quality of life of patients, reduce the morbidity and mortality, This article based on our guidelines for prevention and treatment of hypertension prescribed five kinds of antihypertensive drugs (beta blockers, ACEI, ARB, CCB, diuretics), respectively, its research progress.